Skip to main content

Borderline personality disorder and early psychosis: a narrative review



The purpose of the present review was to summarize the main literature contribution on the relationship between borderline personality disorder (BPD) and early psychosis. While retracing the historical path of the term “borderline”, specific attention was paid to psychotic and psychotic-like symptoms in BPD. Its relationship with At Risk Mental State was evaluated, as well.


This search was conducted on PUBMED/MEDLINE and PsycInfo, looking for “Borderline personality disorder, First Episode Psychosis, Early Psychosis, Ultra-High Risk AND/OR Clinical High Risk” for psychosis.


Eight pertinent papers were identified on this topic. Their main findings were then discussed. The term “borderline” has undergone different changes in meaning and use, despite always referring to states considered on the fence between neurosis and psychosis. However, considering the history of psychopathology and its relationship with diagnostic manuals, little attention has been given to its psychotic features. Being those symptoms highly burdensome, this neglect has often led to misdiagnosis and under-treatment.


Psychotic symptoms in BPD can be severe and distressing. Nonetheless they can be easily neglected, and when found they challenge clinicians in defining a differential diagnosis to distinguish between BPD and Psychosis Spectrum Disorders. Given specific needs and interventions for these different conditions, a dimensional, rather than categorical, approach should be considered, as well as specific care pathways and monitoring should be advised.

History of the concept of “Borderline” disorder

For over a century, since it was first used as a psychoanalytic concept by Stern in 1938 [1], the term “borderline” has experienced a continuous change in use and understanding. In this respect, Stern originally used the word to describe a cluster of patients who were not likely to respond well to psychoanalytic therapy and that he believed was somehow different both from schizophrenia and neuroses [2]. In 1952, Knight [3] was the first to define a “borderline state”, which was conceptually very close to schizophrenia, but also had neurotic features and identified a temporary “ego state” that the patients could enter and exit, thus being affected only for a given time. This idea interestingly resembles a previous one by Zilboorg [4], a psychoanalyst who at first described patients with “ambulatory schizophrenia”, in which it was reported one of the two main roots of the “borderline” concept: i.e., its psychotic features (shared with schizophrenic disorders).

It was in 1967, then, that the term predominantly ceased to identify a mild form of schizophrenia, when Kernberg [5] borrowed it to describe one of the possible levels of personality organizations (namely, “psychotic”, “neurotic” and “borderline”). Quite differently from what Stern had stated, Kernberg used it to qualify a disorder not likely to change during time and closer to our understanding, as well [6].

In the first edition of “A Glossary of Psychoanalytic terms and Concepts” [7], Moore and Fine defined “borderline” as “a descriptive term referring to a group of conditions which manifest both neurotic and psychotic phenomena without fitting unequivocally into either diagnostic category”. It is probably because of this indefiniteness that, despite the many attempts to classify it, it has always remained vague and hardly harmonized in the psychiatric field.

After a long journey through different schools of thought, where a “Borderline Syndrome” [8] and a “Borderline Disorder” [9] were described, in 1979 Spitzer and Endicott theorized the belonging of the “borderline patient” (as it was commonly perceived) either to a Schizotypal Personality Disorder or to an Unstable Personality Disorder [10]. Indeed, even if the term “borderline” had been misused for decades, there was no official description in any previous diagnostic manual. These two terms referred to the two main uses of the word “borderline”, identifying, on one hand, a group of patients more closely related to schizophrenia, and a group of patients predominantly characterized by “unstable affect, interpersonal relationships, job functioning, and sense of identity” [11]. Later, the task force who worked at the third edition of the Diagnostic and Statistical Manual of mental disorders (DSM-III), replaced the term “unstable personality disorder” with “borderline personality disorder”, which was clinically much more usual and wasn’t subject to misinterpretation on the actual stability of personality disorders. Despite Spitzer and Endicott [10] remarked how not mutually exclusive the two diagnoses were, but dimensionally likely to be integrated, psychotic-like features formally ceased to be associated with Borderline Personality Disorder (BPD) (for a brief summary of the history of BPD concept, see Table 1) [12,13,14,15].

Table 1 Brief summary of the history of BPD conceptualizations

Defining psychotic symptoms in BPD

According to the fifth edition of the Diagnostic and Statistical Manual of mental disorders (DSM-5), BPD is described by nine different criteria [16]. Notably, the ninth point mentions “transient, stress-related paranoid ideation or severe dissociative symptoms”, which somehow recalls the historical ambivalence of BPD psychopathology, considered on the fence between psychotic and neurotic symptoms [17]. However, psychotic features have not always been this relevant. It was only in 1994, when the DSM-IV was published, that BPD was acknowledged again a reference to potential psychotic experiences, after being strictly set apart from the schizotypal personality disorder in DSM-III [18].

For the first time in the history of The International Classification of Diseases and Related Health Problems, the 11th revision (ICD-11) includes a description of psychotic-like symptoms “in situations of high affective arousal”, when identifying a borderline pattern for personality disorders [19].

Even if what should or should not be included in the description of BPD could seem only a theoretical issue, it is evident how the accuracy of definitions and criteria can affect the quality of diagnosis [20]. Also, even if the debate around the appropriateness of considering psychotic aspects a core diagnostic feature is still open, it is unarguable that these symptoms can be serious for patients who experience them [21]. What is needed, then, is an effective effort to address patients’ needs and to improve specific treatments, accordingly.

Evaluating the burden: the data so far

Psychotic symptoms in BPD are often underrated and considered temporary or mainly associated with stress [17]. Yet, going deeper into the study of their phenomenology and comparing them to the “proper” psychotic features of schizophrenia, similarities and differences depict a very specific pattern of characteristics.

On one hand, psychotic symptoms in BPD seem to be phenomenologically very similar to those experienced by patients with psychosis spectrum disorders [17, 22]. As a direct consequence, differential diagnosis can be a challenge, thus leading to potential fluctuations in diagnosis and to mistreatment [23]. Also, despite the usual underestimation of psychotic experience in BPD, these symptoms can cause an extremely high burden. Among the most distressing psychotic symptoms in BPD, auditory verbal hallucinations (AVH) play a central role [21] and up to 50% of patients report them [24]. Indeed, some of the most worrying data suggest that AVH in BPD are associated with increased suicidal ideation, suicide attempts and hospitalizations [18, 22, 25]. If compared to those in schizophrenia, AVH in BPD have not been found to differ in frequency, duration, location, loudness, or conviction [17]. Coherently, misdiagnosis mostly happens when AVH differ from the common understanding of the diagnostic manuals and either meet criteria for “First Rank Symptoms” (FRS), and are perceived as coming from outside the head or when of lasting duration [20].

On the other hand, psychotic symptoms differ in some ways between BPD and Psychosis Spectrum Disorders. First, delusions, conceptual disorganization and negative symptoms seem not to be as common as in schizophrenia [17]. When describing AVH, patients with BPD refer a greater distress and negativity in content, yet they seem to be able to manage them better than patients with schizophrenia can, where commentary voices are also more frequent [17]. Given that AVH usually appear earlier in BPD (mean age at onset = 16 years) [22] and that these patients show better resistance, early diagnosis becomes fundamental in preventing the worsening of the symptoms and in aiming at the best possible quality of life.

Interestingly, a recent study [22] compared psychotic symptoms in adolescents with a full-criteria diagnosis of BPD to those experienced by subthreshold BPD patients. The main differences, concerning psychotic symptoms, psychoticism and occupancy, were observed between the full-threshold group and the subthreshold group. Despite the awareness that psychotic symptoms are always a risk factor for worse functioning, regardless of the diagnosis, this finding suggests that a diagnosis of BPD should be a hint for careful management and monitoring.

After defining the significance of psychotic symptoms in BPD, questions around treatment and management arise. There are many reasons why there is a high need for studies to assess the benefit of psychotherapy and antipsychotics in these specific cases [22]. One of the most relevant is the understanding that neurocognitive impairment is known to be greater in BPD with psychotic features [26]. One of the hypotheses is that such impairment can compromise mentalization, which consequently makes social cognition weaker and psychotic symptoms (starting with paranoid phenomena) more likely to arise. The use of antipsychotic drugs, which a recent review [27] reported to be effective in these patients, should also be furtherly discussed. As analyzed in a review by Beatson [20], the most studied antipsychotics for AVH in BPD are olanzapine (2.5–10 mg daily), aripiprazole (2.5–10 mg daily) and quetiapine (50–150 mg daily). Additional results about the efficacy of aripiprazole compared to placebo on AVH in young patients (aged 15 to 25 years old) are awaited soon, since a RCT on the topic is on its way to be published [28].

BPD in at-risk mental states and first-episode psychoses

Given the challenge of differentiating BPD with psychotic features from psychosis spectrum disorders, it is evident that this becomes even more difficult when subtle, subthreshold psychotic symptoms are involved (Table 2). Indeed, since transient psychotic symptoms can be present in both BPD and early psychosis, there is a significant overlap between “At-Risk Mental States” (ARMS) and BPD spectrum psychopathology with attenuated psychotic features at presentation [23].

Table 2 Main empirical findings on BPD psychopathology in patients with early psychosis

Starting from this background, the aim of this narrative review was to examine the main findings on BDP in patients with early psychosis reported in the literature to date.


The search was conducted on MEDLINE/PubMed and psycInfo, looking for “Borderline personality disorder, First Episode Psychosis, Early Psychosis, Ultra-High Risk AND/OR Clinical High Risk” for psychosis. We specifically analyzed papers written in English and published by May 31, 2023. We found 8 pertinent papers on this topic. Their main findings were reported and discussed (see Table 2 for details) [29,30,31,32,33,34].


Clinical similarity on such psychotic features can be possibly explained going deeper into the study of psychopathology. According to a study by Zandersen and Parnas [35], most patients with BPD (considering different stages of illness) meet criteria for a schizophrenia spectrum disorder (which includes Schizotypal Personality Disorder). This observation gives space to different thoughts. First, as it is known from a historical perspective, the choice to differentiate BPD from SPD has long been debated, since many patients often meet both criteria. All things considered, it is logical to assume that BPD as a concept ends up being over-inclusive [36]. This comes as a direct consequence of a methodological shift, which comprises the use of an atheoretical diagnostic manual, based on behaviors rather than personality structure and prototypes [35]. In addition, time should be taken to reflect upon the psychopathological concept of BPD and consider a step “back” to a theoretical understanding of the disorder, which was originally very close to schizophrenia. Specifically, there are some key BPD features, like “identity disturbance” and “feeling of emptiness”, which might resemble other symptoms, nonetheless belonging to the Schizophrenia Spectrum Disorders [35], like the so-called “disorders of the self”. Given the similarity, it would be helpful to build back awareness around the meaning DSM criteria have on a “narrative level” [35] and how deeply these concepts can be explored on a “core” psychopathological level. Differential diagnosis would then be easier. Also, this would allow the acknowledgment of those highly severe cases of BPD, who share a common psychopathological ground with schizophrenia. Interestingly, some effort has been made to determine whether different subgroups of BPD could explain its heterogeneity. Smits and co-workers [37], for instance, identified three clusters of BPD patients sharing common characteristics. Among these, a schizotypal/paranoid type was described as very close to SPD, with introjective and psychotic-like features, which inevitably posed questions around its risk for psychosis. This subgroup was not as represented as the Core BPD and the Extravert/Externalizing subtypes in the study, yet seemed to be more likely to present late at mental health services, thus being more vulnerable to negative outcomes.

So far, when examining ARMS, no predictive meaning towards transition to psychosis has been found in those patients who presented BPD symptoms [33]. Nonetheless, the severity of BPD psychopathology hasn’t been associated either with clinical higher or lower risk for psychosis, thus suggesting how every patient with BPD having attenuated psychotic symptoms and/or meeting cognitive-perceptive basic symptoms criteria (i.e., COGDIS and COPER) should be monitored, regardless of the scores [31, 33] (see also Table 2, for details on main empirical findings about BPD psychopathology in early psychosis). Then, this is even more important, since it is known that, while keeping in mind that not all people with BPD need to be screened for psychosis, their co-occurrence results in a worse functioning and response to treatment [38]. Indeed, a possibility of co-occurring diagnoses of BPD and schizophrenia spectrum disorder may also occur. In this respect, Bahorik and Eack [38] reported that at 1-year follow-up, patients with schizophrenia and comorbid BPD showed significantly less improvement in psychiatric symptomatology (particularly hostility and suspiciousness), as well as global functioning, and were re-hospitalized at significantly higher rates than individuals without BPD. The authors suggested that the co-occurrence of schizophrenia and BPD was not infrequent and that BPD had a significant negative longitudinal impact on the course and outcome of subjects with schizophrenia.

When it comes to analyzing the impact of BPD on First Episode Psychosis (FEP), recent findings suggest how the overlap of the two disorders can lead to an increased risk for depression and self-harm [34]. Surprisingly, despite a higher severity, this combination is not associated with a major number of hospitalizations. One possible explanation is that patients with BPD may undergo a substantial under-treatment, probably due to a common underestimation of their symptoms.

Considering that, according to Francey and colleagues [32], the subgroup of patients presenting with FEP and BPD can represent up to a quarter of the total cases of FEP, specific attention should be paid to the treatment. The same study reports how this cluster of patients is more likely to receive a lower dosage of antipsychotics. This finding underlies how specific guidelines would be helpful in avoiding a stigmatizing approach and consequent mistreatment.


BPD psychopathology can be found in patients presenting with early psychosis. Also, psychotic, or psychotic-like symptoms can be the main features already at the first contact of BPD patients with mental healthcare services. These statements lead to two main clinical considerations. First, personality structure and pathology should be explored in people presenting with early psychosis, since it is known personality disorders can hide specific needs and affect the response to treatment. This may also require developing new clinical guidelines and effective treatments for young patients with early psychosis and co-occurring BPD that take into account “premorbid” and interpersonal aspects of their presenting problems. Secondly, special attention should be paid to BPD patients who carry a high burden of disease, with intense psychological suffering and bad functioning. Indeed, the severity of symptoms and functional impairment should alert mental healthcare professionals and lead to a further investigation of basic symptoms and potential psychotic psychopathology (either attenuated or full-blown). In this respect, psychotic symptoms can be viewed as “trans-diagnostic phenomena” [39], with psychotic experiences in schizophrenia spectrum disorders and BPD sharing similarities, which raises the question of whether they are underlain by the same neural mechanism [40] and have common risk factors (such as previous traumatic events, family history of psychotic disorder, substance misuse) [41]. Taking this into account, theoretical questions around how BPD should be defined and perceived inevitably arise. Should BPD meeting psychotic symptoms or ARMS criteria be considered more severe and worthy a personalized approach? If so, should psychotic experiences be reconsidered as core diagnostic criteria? Since definitions do not always meet the reality of everyday clinical practice, what, anyhow, should be achieved is the understanding of the high suffering this kind of patients can go through. Moreover, the evidence that BPD patients with psychotic signs are often at higher risk of developing a wider range of negative outcomes (including suicidal thinking and behavior) cannot be ignored, especially when considering treatment and monitoring.

In conclusion, sometimes understanding this specific vulnerability requires mental health professionals to go beyond narrow diagnostic categories and embrace what is known as a “dimensional approach” to psychopathology and psychiatric disorders. Future studies on early psychosis and BPD should thus recognize both the dimensional and dynamic nature of psychopathological symptoms and evolving phenotypes across the transition from childhood to adulthood by adopting a clinical staging approach [42]. Such an approach needs to include the measurement of personality pathology, in order to focus on the etiological factors and treatment options for psychotic symptoms in BPD. Also, taking into account a “network approach to psychopathology” [43, 44], common risk factors, such as trauma and substance abuse, could be considered as possibly interacting with each other, thus concurring to overlapping psychopathological categories. This could be the first step in the complex path to better understand the relationship between psychosis spectrum disorders and psychotic experiences being found in severe personality disorders.

Availability of data and materials

Not applicable.


  1. Stern A. Psychoanalytic investigation and therapy in the borderline group of neuroses. Psychoanal Q. 1938;7(4):467–89.

    Article  Google Scholar 

  2. Peters CP. An historical review of the borderline concept. Occup Ther Ment Health. 2008;3(3):1–18.

    Article  Google Scholar 

  3. Knight RP. Borderline states. Bull Menninger Clin. 1953;17(1):1–12.

    CAS  PubMed  Google Scholar 

  4. Zilboorg G. Ambulatory schizophrenia. Psychiatry. 1941;4(2):149–55.

    Article  Google Scholar 

  5. Kernberg O. Borderline personality organization. J Am Psychoanal Assoc. 1967;15(3):641–85.

    Article  CAS  PubMed  Google Scholar 

  6. Hörz-Sagstetter S, Ohse L, Kampe L. Three dimensional approaches to personality disorders: a review on personality functioning, personality structure, and personality organization. Curr Psychiatry Rep. 2021;23(7):54.

    Article  Google Scholar 

  7. Moore BE, Fine BD. A glossary of psychoanalytic terms and concepts. New York (NY): American Psychoanalytic Association; 1968.

  8. Grinker R, Werble B, Drye RC. The borderline syndrome: a behavioral study of ego-functions, I Edition. New York (NY): Joyce and Company; 1968.

  9. Gunderson JG, Singer MT. Defining borderline patients: an overview. Am J Psychiatry. 2006;132(1):1–10.

    Article  Google Scholar 

  10. Spitzer RL, Endicott J. Justification for separating schizotypal and borderline personality disorders. Schizophr Bull. 1979;5(1):95–104.

    Article  CAS  PubMed  Google Scholar 

  11. Spitzer RL, Endicott J, Gibbon M. Crossing the border into borderline personality and borderline schizophrenia: the development of criteria. Arch Gen Psychiatry. 1979;36(1):17–24.

    Article  CAS  PubMed  Google Scholar 

  12. Bleuler E. Dementia praecox oder grouppen schizophrenien. Leiptzig: Springer; 1913.

    Google Scholar 

  13. Freud S. On beginning the treatment (further recommendations on the technique of psychoanalysis). Wien: Springer Verlag; 1913.

    Google Scholar 

  14. Hoch P, Polatin P. Pseudoneurotic forms of schizophrenia. Psychiatr Q. 1949;23(2):248–76.

    Article  CAS  PubMed  Google Scholar 

  15. Stern A. The transference in the borderline group of neuroses. J Am Psychoanal Assoc. 1957;5(2):348–50.

    Article  CAS  PubMed  Google Scholar 

  16. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). Washington DC: American Psychiatric Association; 2013.

  17. Cavelti M, Thompson K, Chanen AM, Kaess M. Psychotic symptoms in borderline personality disorder: developmental aspects. Curr Opin Psychol. 2021;37:26–31.

    Article  PubMed  Google Scholar 

  18. Kingdon DG, Ashcroft K, Bhandari B, Gleeson S, Warikoo N, Symons M, Taylor L, Lucas E, Mahendra R, Ghosh S, Mason A, Badrakalimuthu R, Hepworth C, Read J, Mehta R. Schizophrenia and borderline personality disorder. J Nerv Ment Dis. 2010;198(6):399–403.

    Article  PubMed  Google Scholar 

  19. World Health Organization (WHO). International Classification of Diseases and related health problems, 11th edition (ICD-11). Geneve: WHO Press; 2019.

  20. Beatson J. Borderline personality disorder and auditory verbal hallucinations. Australas Psychiatry. 2019;27(6):548–51.

    Article  PubMed  Google Scholar 

  21. Hayward M, Jones AM, Strawson WH, Quadt L, Larsson DEO, Silva M, Davies G, Fielding-Smith S, Hazell CM, Critchley HD, Garfinkel SN. A cross-sectional study of auditory verbal hallucinations experienced by people with a diagnosis of borderline personality disorder. Clin Psychol Psychother. 2022;29(2):631–41.

    Article  PubMed  Google Scholar 

  22. Thompson KN, Cavelti M, Chanen AM. Psychotic symptoms in adolescents with borderline personality disorder features. Eur Child Adolesc Psychiatry. 2019;28(7):985–92.

    Article  PubMed  Google Scholar 

  23. West ML, Guest RM, Carmel A. Comorbid early psychosis and borderline personality disorder: conceptualizing clinical overlap, etiology, and treatment. Personal Ment Health; 2021; 15(3): 208–22.

  24. Merrett Z, Rossell SL, Castle DJ. Comparing the experience of voices in borderline personality disorder with the experience of voices in a psychotic disorder: a systematic review. Austr N Z J Psychiatry. 2016;50(7):640–8.

    Article  Google Scholar 

  25. Niemantsverdriet MBA, Slotema CW, Blom JD, Franken IH, Hoek HW, Sommer IEC, van der Gaag M. Hallucinations in borderline personality disorder: prevalence, characteristics and associations with comorbid symptoms and disorders. Sci Rep. 2017;7(1):13920.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Carrasco JL, Mellor-Marsá B, Mallardo L, López-Villatoro JM, Montes A, de la Vega I, Diaz-Marsá M. Persistent psychotic symptoms and neurocognitive deficits in borderline personality disorder. Schizophr Res. 2021;232:109–11.

    Article  PubMed  Google Scholar 

  27. Slotema CW, Blom JD, Niemantsverdriet MBA, Sommer IEC. Auditory verbal hallucinations in borderline personality disorder and the efficacy of antipsychotics: a systematic review. Front Psychiatry. 2018;9:347.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chanen AM, Betts J, Jackson H, McGorry P, Nelson B, Cotton SM, Bartholomeusz C, Jovev M, Ratheesh A, Davey C, Pantelis C, McCutcheon L, Francey S, Bhaduri A, Lowe D, Rayner V, Thompson K. Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: protocol for the VERBATIM randomized controlled trial. Early Interv Psychiatry. 2019;13(6):1373–81.

    Article  PubMed  Google Scholar 

  29. Gleeson JFM, Chanen A, Cotton SM, Pearce T, Newman B, McCutcheon L. Treating co-occurring first-episode psychosis and borderline personality: a pilot randomized controlled trial. Early Interv Psychiatry. 2012;6(1):21–9.

    Article  PubMed  Google Scholar 

  30. Schultze-Lutter F, Klosterkötter J, Michel C, Winkler K, Ruhrmann S. Personality disorders and accentuations in at-risk persons with and without conversion to first-episode psychosis. Early Interv Psychiatry. 2012;6(4):389–98.

    Article  PubMed  Google Scholar 

  31. Ryan J, Graham A, Nelson B, Yung A. Borderline personality pathology in young people at ultra-high risk of developing a psychotic disorder. Early Interv Psychiatry. 2017;11(3):208–14.

    Article  PubMed  Google Scholar 

  32. Francey SM, Jovev M, Phassouliotis C, Cotton SM, Chanen AM. Does co-occurring borderline personality disorder influence acute phase treatment for first-episode psychosis? Early Interv Psychiatry. 2018;12(6):1166–72.

    Article  PubMed  Google Scholar 

  33. Paust T, Theodoridou A, Müller M, Wyss C, Obermann C, Rössler W, Heekeren K. Borderline personality pathology in an at-risk mental state sample. Front Psychiatry. 2019;10:838.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Schandrin A, Francey S, Nguyen L, Whitty D, McGorry P, Chanen AM, O’Donoghue B. Co-occurring first-episode psychosis and borderline personality pathology in an early intervention for psychosis cohort. Early Interv Psychiatry. 2022;17:588–96.

    Article  PubMed  Google Scholar 

  35. Zandersen M, Parnas J. Exploring schizophrenia spectrum psychopathology in borderline personality disorder. Eur Arch Psychiatry Clin Neurosci. 2020;270(8):969–78.

    Article  PubMed  Google Scholar 

  36. Zandersen M, Henriksen MG, Parnas J. A recurrent question: what is borderline? J Personal Disord. 2019;3(3):341–69.

    Article  Google Scholar 

  37. Smits ML, Feenstra DJ, Bales DL, de Vos J, Lucas Z, Verheul R, Luyten P. Subtypes of borderline personality disorder patients: a cluster-analytic approach. Borderline Personal Disord Emot Dysregulation. 2017;4(1):16.

    Article  Google Scholar 

  38. Bahorik AL, Eack SM. Examining the course and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder. Schizophr Res. 2010;124(1–3):29–35.

    Article  PubMed  Google Scholar 

  39. Tschöke S, Kratzer L. Psychotic experiences in trauma-related disorders and borderline personality disorder. Lancet Psychiatry. 2023;10(1):5–6.

    Article  PubMed  Google Scholar 

  40. Schutte MJL, Linszen MMJ, Marschall TM, Effytche DH, Koops S, van Dellen E, Heringa SM, Slooter AJC, Teunisse R, van den Heuvel OA, Lemstra AW, Foncke EMJ, Slotema CW, de Jong J, Rossell SL, Sommer IC. Hallucinations and other psychotic experiences across diagnoses: a comparison of phenomenological features. Psychiatry Res. 2020;292:113314.

    Article  PubMed  Google Scholar 

  41. Barrera A, Bajorek T, Dekker R, Hothi G, Lewis A, Pearce S. A phenomenological exploration of the voices reported by borderline personality and schizophrenia patients. Psychopathology. 2021;54:159–68.

    Article  PubMed  Google Scholar 

  42. Raballo A, Poletti M, Preti A, McGorry P. Clinical high risk for psychosis in children and adolescents: a meta-analysis of transition prevalences. Schizophr Res. 2022;243:254–61.

    Article  PubMed  Google Scholar 

  43. Robinaugh DJ, Hoekstra RHA, Toner ER, Borsboom D. The network approach to psychopathology: a review of the literature 2008–2018 and an agenda for future research. Psychol Med. 2019;50:353–66.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Pelizza L, Leuci E, Quattrone E, Azzali S, Paulillo G, Pupo S, Pellegrini P, Biancalani A, Gammino L, Menchetti M. Borderline personality disorder vs mood disorders: clinical comparisons in young people treated within an “Early Intervention” service for first episode psychosis. Eur J Psychiatry. 2023; 37: 100219. Doi:

Download references


This review received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations



LP had the idea for the review; AB and LP performed the literature search and analysis. AB wrote the first draft of the manuscript. LP and MM crucially revised the manuscript.

Corresponding author

Correspondence to Lorenzo Pelizza.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biancalani, A., Pelizza, L. & Menchetti, M. Borderline personality disorder and early psychosis: a narrative review. Ann Gen Psychiatry 22, 44 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: